Jim O'Neill, a Silicon Valley investor and advocate for unproven COVID treatments, is set to lead the CDC, sparking concerns over public health policies. His ties with Health Secretary Robert F. Kennedy Jr. may reshape America's health agenda.
Prepare for an exhilarating launch as NASA and SpaceX send 5,000 pounds of vital supplies and groundbreaking experiments to the International Space Station. Tune in for live coverage!
Discover how researchers at IBM and Moderna have leveraged quantum computing to predict the complex protein structure of mRNA, marking a significant advancement in vaccine technology.
Scientists have developed a groundbreaking 'disease-on-a-chip' model for ALS using stem cells, paving the way for potential new treatments. This innovative approach mimics early disease stages and could revolutionize ALS research.
In a stunning move, the FDA has put clinical trials for Sarepta's gene therapy on hold due to alarming safety concerns after multiple patient deaths linked to acute liver failure. The company faces scrutiny as it navigates the fallout.
Sarepta Therapeutics is under fire as another patient succumbs to acute liver failure linked to its gene therapy trial for muscular dystrophy, adding to the recent deaths of two teenage boys.
Colossal Biosciences aims to resurrect the giant moa, but experts warn that the task is fraught with challenges. Discover the complexities of de-extinction and the ethical dilemmas involved.
In a surprising turn, ultra-wealthy family offices are ramping up investments in biotechnology and entertainment, signaling a shift in investment strategies. Learn about the latest deals and why patience is key in biotech.
Researchers have discovered a groundbreaking method to convert plastic waste into paracetamol using genetically modified E coli, paving the way for sustainable drug production and environmental cleanup.
In a bold move, a Turkish private equity firm has injected $39 million into a Harvard lab, aiming to pioneer new therapies for metabolic conditions. This unique financing approach could reshape academic funding in the future.
